Navigation Links
NSET recognizes needs related to engineered nanoscale materials

A document recognizing environmental, health, and safety (EHS) research and information needs related to understanding// and management of possible risks of engineered nanoscale materials was released by the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the National Science and Technology Council's Committee on Technology. The report is accessible at www.nano.gov.

The document will be useful for Federal agencies taking part in the National Nanotechnology Initiative (NNI) in informing and guiding research programs. Industry, universities, and other nongovernment research entities can also benefit from this document by obtaining the knowledge and understanding necessary to enable risk assessment and management of nanomaterials.

Nanotechnology is expected to contribute to scientific and technological advances in a wide range of fields, including energy, electronics, materials, and medicine. Many of the benefits of nanotechnology arise from the fact that nanomaterials exhibit properties and behavior different from those of materials at larger scales. At the nanoscale, material properties vary as the function of size, which not only enables new benefits, but also may lead to health and environmental risks.

That a technology could offer both benefits and, at the same time, potential risk is not unique to nanotechnology. Other common examples are electricity, household cleaning supplies, gasoline, and medical X-rays. When risks are understood, however, they can be successfully managed and the benefits of the technology can be realized.

"This document is extremely important in that it is the result of a highly collaborative effort by the Federal agencies that participate in the NNI to identify and agree upon major EHS research needs. It reflects inputs from the Federal regulatory agencies and describes the EHS research and information needed to enable sound risk assessment and risk management decision mak
'"/>




Page: 1 2

Related medicine news :

1. SNM recognizes exemplary contributors in nuclear medicine
2. Body mass index guide needs revision
3. Risk of heart disease prediction needs updating
4. Air pollution combined with greater medical needs
5. Treatment of postpartum depression needs to be personalized
6. FDA needs to be more vigilant in monitoring, tissue banks.
7. Australia: Salt needs More of Iodine
8. A new disease: couch potato: needs drug therapy
9. Lawn Mower injuries - children needs precaution
10. NHS needs changes like ‘Tesco and ‘Toyot’
11. India needs dental health leadership, says expert
Post Your Comments:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
... want to breastfeed. The study shows breastfed inf...// Previous research indicated breastfeeding redu...d major weaknesses. In a recent study which was do...s included 216 teenagers who were randomly given b...
...age-related macular degeneration and cataracts may... new study. A cataract involves the lens of the ey... In a study of 4,753 people aged 55 to 81, people ... condition that causes gradual vision loss, had a ...
... lung function tests. It is used to test for a var...veness // of treatment. The patient takes a deep b...r to the best of their ability. The spirometer mea...ickly the air was expelled from the lungs.New rese...
...tions affecting children in the United States. A ...infections in early childhood are more likely to b...children between 2 and 11 years old. The complete ...wed, as well as demographic information on the chi...
Other Medicine News:
(Date:10/13/2008)... from Multiple Cancer Populations Facilitates ..., Mich., Oct. 13 /- Rubicon Genomics,...rick to amplify DNA samples for The,Cancer Atlas G...amplify and standardize total genomic,DNA from 3,0...The Rubicon,GenomePlex(TM) Whole Genome Amplificat...
(Date:10/10/2008)...RK, Calif., Oct. 10 /-,XTEN...lans to present,long-term follow-up data from the ...the Cardiovascular Research Foundation,s (CRF) twe...utics (TCT) meeting in Washington, DC.,The CUSTOM ...o investigate,the safety and efficacy of the Custo...
(Date:10/10/2008).... 10 /- TriReme Medical Inc. (TMI),an... the CE (Conformite,Europeenne) marking and commer...ystem, a unique main vessel stent system specially...., Representing the next generation in bifurcatio...se in a quarter of the 2.2 million,angioplasty pro...
(Date:10/9/2008)...cience Institute, Navigenics, Affymetrix and,Micro...GO, Oct. 9 /- A consortium of health ...forces in a first-of-its-kind,research study to as...ting,on people who choose to receive such screenin... certain diseases., Sponsored by Scripps Translat...
Breaking Medicine Technology:Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Simvastatin Leads Pfizers Lipitor in Second Line Patient Share for the Treatment of Dyslipidemia 19176 1Simvastatin Leads Pfizers Lipitor in Second Line Patient Share for the Treatment of Dyslipidemia 19176 2Simvastatin Leads Pfizers Lipitor in Second Line Patient Share for the Treatment of Dyslipidemia 19176 3Medifast Inc Names Barry B Bondroff CPA to Board of Directors 19174 1Medifast Inc Names Barry B Bondroff CPA to Board of Directors 19174 2CEOs From Multiple Health Industries Announce Consensus Plan to Reform U S Health Care 19172 1CEOs From Multiple Health Industries Announce Consensus Plan to Reform U S Health Care 19172 2CEOs From Multiple Health Industries Announce Consensus Plan to Reform U S Health Care 19172 3Why Our Kids Cant Breathe in Our Communities 19169 1Why Our Kids Cant Breathe in Our Communities 19169 2Why Our Kids Cant Breathe in Our Communities 19169 3
...Mullerian Inhibiting Substance (MIS), also known a...glycoprotein dimer composed of two 72 kDa monomers...to the transforming growth factor-? (TGF-?) superf... and activin glycoproteins (2). All members of thi...
The STA Compact CT is a completely automated, benchtop hemostasis analyzer capable of performing clotting assays in random access mode. The system's unique method of sample management offers high thr
...Alpha Fetoprotein (AFP) is a 68 kDa protein, which...tal liver and yolk sac [1]. Human fetal serum AFP...n rates reach 19-26 g/min during mid-gestation (14...es of total fetal AFP continue to increase after m...
Compensating for movement is critical to weighing patients in wheelchairs. Thats why this scale has the exclusive technology to do just that. Extremely durable, with state-of-the-art technology, thes
Medicine Products: